Biotrin International Overview

  • Founded
  • 1992
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 75
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $39.1M
Latest Deal Amount

Biotrin International General Information

Description

Developer of products that are used for the early detection of infectious diseases and organ damage. The company provides a range of tests for the clinician and research scientist for the detection of new and emerging viruses biomarkers to assess organ and tissue damage.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • 93 The Rise Mount Merrio
  • Dublin
  • Ireland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotrin International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 09-Jul-2008 $39.1M 000.00 Completed Generating Revenue
5. Buyout/LBO (MBO) 31-Aug-2006 000.00 000.00 Completed Generating Revenue
4. Buyout/LBO (MBO) 08-May-2003 000.00 000.00 000.00 Completed Generating Revenue
3. Merger/Acquisition 08-Nov-2002 000.00 000.00 Cancelled Generating Revenue
2. Later Stage VC 11-Apr-1997 $12.3M $21.8M Completed Generating Revenue
1. Later Stage VC $9.5M $9.5M Completed Generating Revenue
To view Biotrin International’s complete valuation and funding history, request access »

Biotrin International Executive Team (1)

Name Title Board Seat Contact Info
Cormac Kilty Ph.D Chief Executive Officer & Founder
To view Biotrin International’s complete executive team members history, request access »

Biotrin International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotrin International Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3i Group PE/Buyout Minority 000 0000 000000 0
Bank of Scotland Corporation Minority 000 0000 000000 0
Credit Suisse Investment Bank Minority 000 0000 000000 0
Delta Partners Venture Capital Minority 000 0000 000000 0
Dr. Schmidt Biotech Other Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Biotrin International Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (000000000 04-May-2012 000000000000000000 0000 Decision/Risk Analysis 000000 00000 00.0
To view Biotrin International’s complete acquisitions history, request access »